A carregar...
Impact of Repeated Cycles of EGF Bispecific Angiotoxin (eBAT) Administered at a Reduced Interval from Doxorubicin Chemotherapy in Dogs with Splenic Hemangiosarcoma
We previously reported that eBAT, an EGF-targeted angiotoxin, was safe and improved overall survival for dogs with splenic hemangiosarcoma when added to the standard of care in a single cycle of three administrations in the minimal residual disease setting. Our objective for the SRCBST-2 trial was t...
Na minha lista:
| Publicado no: | Vet Comp Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7501152/ https://ncbi.nlm.nih.gov/pubmed/32187827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vco.12590 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|